» Articles » PMID: 31201718

Hypoxia and Metabolism in Metastasis

Overview
Date 2019 Jun 16
PMID 31201718
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The hypoxic microenvironment is one of the major features of solid tumors, which regulates cell malignancy in multiple ways. As a response to hypoxia, a large number of target genes involved in cell growth, metabolism, metastasis and immunity are activated in cancer cells. Hypoxia-inducible factor 1 (HIF-1), as a heterodimeric DNA-binding complex, is comprised of a constitutively expressed HIF-1β subunit and an oxygen sensitive HIF-1α subunit, thus, adapts to decreased oxygen availability as a transcriptional factor. HIF-1 regulates many genes involved in tumorigenesis. Here, we focus on cancer cell metabolism and metastasis regulated by hypoxia.

Citing Articles

FUNDC1 predicts Poor Prognosis and promotes Progression and Chemoresistance in Endometrial Carcinoma.

Tang L, Chen J, Wu Z, Wang L, Lai Y, Chen Z J Cancer. 2024; 15(20):6490-6504.

PMID: 39668821 PMC: 11632979. DOI: 10.7150/jca.96877.


Cellular Senescence and Extracellular Vesicles in the Pathogenesis and Treatment of Obesity-A Narrative Review.

Liang Y, Kaushal D, Wilson R Int J Mol Sci. 2024; 25(14).

PMID: 39063184 PMC: 11276987. DOI: 10.3390/ijms25147943.


Murine Breast Cancer Radiosensitization Using Oxygen Microbubbles and Metformin: Vessels Are the Key.

Drzal A, Dziurman G, Hola P, Lechowski J, Delalande A, Swakon J Int J Mol Sci. 2023; 24(15).

PMID: 37569531 PMC: 10418665. DOI: 10.3390/ijms241512156.


Mitochondrial plasticity supports proliferative outgrowth and invasion of ovarian cancer spheroids during adhesion.

Grieco J, Compton S, Bano N, Brookover L, Nichenko A, Drake J Front Oncol. 2023; 12:1043670.

PMID: 36727073 PMC: 9884807. DOI: 10.3389/fonc.2022.1043670.


Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.

Ramirez-Tortosa C, Alonso-Calderon R, Galvez-Navas J, Perez-Ramirez C, Quiles J, Sanchez-Rovira P Cancers (Basel). 2022; 14(21).

PMID: 36358811 PMC: 9656699. DOI: 10.3390/cancers14215393.